New Delhi, June 29 -- Gujarat-based pharmaceutical giant Torrent Pharma announced on Sunday, 29 June 2025, that it is in definitive agreements with global investment giant KKR to acquire a majority stake in JB Chemicals, according to an exchange filing.

The potential acquisition details show that the company plans to acquire J. B. Chemicals and Pharmaceuticals at an equity valuation of Rs.25,689 crore on a fully diluted basis, which will be followed by a merger of the two companies.

The deal is set to be carried out in a few phases, where Torrent Pharma in the first phase will acquire a 46.39% stake through a share purchase agreement (SPA). The first part of the acquisition will be at a total value of Rs.11,917 crore at the rate of Rs.1...